| Entry |
|
|---|
| Name |
Trotabresib (USAN) |
|---|
| Formula |
C21H21NO4S
|
|---|
| Exact mass |
383.1191
|
|---|
| Mol weight |
383.46
|
|---|
| Structure |
|
|---|
| Efficacy |
Antineoplastic, BET inhibitor |
|---|
| Target |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
Other
BRD2
D12006 Trotabresib (USAN)
BRD3
D12006 Trotabresib (USAN)
BRD4
D12006 Trotabresib (USAN)
BRDT
D12006 Trotabresib (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 27
1 C8y C 22.7500 -16.3100
2 C8y C 22.7500 -17.7100
3 C8y C 21.5600 -18.4100
4 N4y N 20.3000 -17.7100
5 C8x C 20.3000 -16.3100
6 C8y C 21.5600 -15.6100
7 C8x C 23.9400 -15.6100
8 C8x C 25.2000 -16.3100
9 C8x C 25.2000 -17.7100
10 C8x C 23.9400 -18.4100
11 O5x O 21.5600 -19.8100
12 C1a C 19.1100 -18.4100
13 C8y C 21.5600 -14.2100
14 C8x C 22.7500 -13.5100
15 C8y C 22.7500 -12.1100
16 C8x C 21.5600 -11.4100
17 C8x C 20.3700 -12.1100
18 C8y C 20.3700 -13.5100
19 O2a O 19.1800 -14.2100
20 C1b C 17.9900 -13.5100
21 C1y C 16.8000 -14.2100
22 C1x C 15.4000 -14.2100
23 C1x C 16.1000 -15.4000
24 S4a S 23.9400 -11.4100
25 O3c O 24.6400 -12.6000
26 O3c O 23.2400 -10.2200
27 C1a C 25.2000 -10.7100
BOND 30
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 2
8 7 8 1
9 8 9 2
10 9 10 1
11 2 10 2
12 3 11 2
13 4 12 1
14 6 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 13 18 1
21 18 19 1
22 19 20 1
23 20 21 1
24 21 22 1
25 22 23 1
26 23 21 1
27 15 24 1
28 24 25 2
29 24 26 2
30 24 27 1
|
|---|
